CLINICAL EXPERIENCE OF NEXAVAR (SORAFENIB) APPLICATION IN PATIENTS WITH METASTATIC DIFFERENTIATED THYROID CANCER RESISTANT TO THERAPY 131I

Cover Page

Cite item

Full Text

Abstract

The treatment choice of differentiated thyroid cancer resistant to therapy 131I to be restricted just to systemic methods. Traditional chemotherapy demonstrated no clinically relevant effectiveness but high toxicity. With the introduction into clinical practice of multi-kinase inhibitor was able to significantly improve treatment outcomes.

The paper demonstrated two patients with the incurable of differentiated thyroid cancer resistant to therapy 131I. All patients received Nexavar (sorafenib). Its therapeutic effectiveness varied from partial response to long-term stabilization.

About the authors

P. A. Isaev

Medical Radiology Research Center, Ministry of Health of Russia, Obninsk

Author for correspondence.
Email: isaev@mrrc.obninsk.ru
Russian Federation

P. O. Rumyantsev

Endocrinology Research Center, Ministry of Health of Russia, Moscow

Email: isaev@mrrc.obninsk.ru
Russian Federation

V. V. Polkin

Medical Radiology Research Center, Ministry of Health of Russia, Obninsk

Email: isaev@mrrc.obninsk.ru
Russian Federation

A. A. Ilyin

Medical Radiology Research Center, Ministry of Health of Russia, Obninsk

Email: isaev@mrrc.obninsk.ru
Russian Federation

D. Yu. Syomin

Medical Radiology Research Center, Ministry of Health of Russia, Obninsk

Email: isaev@mrrc.obninsk.ru
Russian Federation

T. A. Agababyan

Medical Radiology Research Center, Ministry of Health of Russia, Obninsk

Email: isaev@mrrc.obninsk.ru
Russian Federation

S. V. Vasilkov

Medical Radiology Research Center, Ministry of Health of Russia, Obninsk

Email: isaev@mrrc.obninsk.ru
Russian Federation

V. S. Medvedev

Medical Radiology Research Center, Ministry of Health of Russia, Obninsk

Email: isaev@mrrc.obninsk.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36990 от  21.07.2009.